ISM

Clinical trials for ISM explained in plain language.

Never miss a new study

Get alerted when new ISM trials appear

Sign up with your email to follow new studies for ISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets debilitating mast cell disease symptoms

Symptom relief Ongoing

This study is testing whether an investigational drug called bezuclastinib can better control symptoms in people with nonadvanced systemic mastocytosis, a condition where too many mast cells build up in the body. The trial will compare the drug plus standard care against a placeb…

Matched conditions: ISM

Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Symptom relief

Last updated Mar 12, 2026 13:50 UTC

ISM

Get alerted when new ISM trials appear

New drug trial targets debilitating mast cell disease symptoms